Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Parkinson Disease | 29 | 2023 | 2775 | 1.730 |
Why?
|
Alzheimer Disease | 33 | 2023 | 8037 | 0.760 |
Why?
|
Perimenopause | 2 | 2021 | 139 | 0.670 |
Why?
|
Vasomotor System | 1 | 2019 | 209 | 0.650 |
Why?
|
alpha-Synuclein | 6 | 2017 | 723 | 0.610 |
Why?
|
Amyloid beta-Peptides | 15 | 2023 | 3587 | 0.600 |
Why?
|
Activities of Daily Living | 12 | 2023 | 2418 | 0.550 |
Why?
|
Lewy Body Disease | 6 | 2016 | 229 | 0.540 |
Why?
|
Cultural Diversity | 2 | 2020 | 359 | 0.510 |
Why?
|
Nasal Obstruction | 3 | 2021 | 151 | 0.480 |
Why?
|
Disease Progression | 21 | 2023 | 13284 | 0.460 |
Why?
|
Rhinoplasty | 3 | 2021 | 226 | 0.430 |
Why?
|
Cholecalciferol | 2 | 2014 | 537 | 0.420 |
Why?
|
Apathy | 4 | 2017 | 96 | 0.390 |
Why?
|
Longitudinal Studies | 28 | 2022 | 13989 | 0.380 |
Why?
|
Cognition Disorders | 13 | 2021 | 4043 | 0.370 |
Why?
|
Glucosylceramidase | 3 | 2021 | 124 | 0.360 |
Why?
|
Memory | 7 | 2023 | 2174 | 0.340 |
Why?
|
Neuropsychological Tests | 23 | 2021 | 6993 | 0.330 |
Why?
|
Nasal Septum | 2 | 2020 | 127 | 0.320 |
Why?
|
Vitamin D Deficiency | 2 | 2014 | 1343 | 0.300 |
Why?
|
Migraine Disorders | 1 | 2019 | 1620 | 0.290 |
Why?
|
Aging | 13 | 2020 | 8664 | 0.280 |
Why?
|
Dopamine Plasma Membrane Transport Proteins | 2 | 2021 | 422 | 0.270 |
Why?
|
Caregivers | 3 | 2022 | 2094 | 0.260 |
Why?
|
Aged | 73 | 2024 | 163280 | 0.260 |
Why?
|
tau Proteins | 8 | 2023 | 1868 | 0.250 |
Why?
|
Psychiatric Status Rating Scales | 10 | 2018 | 6038 | 0.250 |
Why?
|
Statistics as Topic | 1 | 2011 | 2373 | 0.250 |
Why?
|
Humans | 135 | 2024 | 744343 | 0.250 |
Why?
|
Cognition | 11 | 2023 | 6770 | 0.250 |
Why?
|
Female | 98 | 2024 | 380194 | 0.240 |
Why?
|
Gangliosidoses, GM2 | 1 | 2023 | 17 | 0.240 |
Why?
|
Research Design | 3 | 2023 | 5987 | 0.230 |
Why?
|
Brain | 13 | 2020 | 26385 | 0.230 |
Why?
|
Lasers | 2 | 2018 | 952 | 0.230 |
Why?
|
Subarachnoid Hemorrhage | 2 | 2021 | 1018 | 0.230 |
Why?
|
Social Participation | 3 | 2021 | 173 | 0.230 |
Why?
|
Dendritic Cells | 3 | 2018 | 2725 | 0.220 |
Why?
|
Male | 92 | 2024 | 350118 | 0.220 |
Why?
|
Randomized Controlled Trials as Topic | 3 | 2023 | 9959 | 0.220 |
Why?
|
Haptoglobins | 1 | 2024 | 165 | 0.220 |
Why?
|
Hyperbaric Oxygenation | 1 | 2023 | 163 | 0.210 |
Why?
|
Calciphylaxis | 1 | 2023 | 124 | 0.200 |
Why?
|
Aged, 80 and over | 37 | 2021 | 57776 | 0.200 |
Why?
|
Dementia | 5 | 2017 | 2518 | 0.200 |
Why?
|
Depression | 8 | 2021 | 7766 | 0.200 |
Why?
|
Carbolines | 3 | 2021 | 265 | 0.200 |
Why?
|
Cyclonic Storms | 1 | 2023 | 119 | 0.190 |
Why?
|
Cerebral Cortex | 6 | 2021 | 5708 | 0.190 |
Why?
|
Dacryocystitis | 1 | 2021 | 70 | 0.190 |
Why?
|
Positron-Emission Tomography | 12 | 2023 | 6234 | 0.190 |
Why?
|
Cross-Sectional Studies | 24 | 2021 | 25043 | 0.190 |
Why?
|
Basal Ganglia Diseases | 1 | 2021 | 149 | 0.180 |
Why?
|
Skin | 3 | 2018 | 4364 | 0.180 |
Why?
|
Anesthetics, Dissociative | 1 | 2020 | 80 | 0.180 |
Why?
|
Entorhinal Cortex | 2 | 2023 | 272 | 0.180 |
Why?
|
Putamen | 1 | 2021 | 291 | 0.180 |
Why?
|
Erythrocytes, Abnormal | 1 | 2020 | 125 | 0.180 |
Why?
|
Splenomegaly | 1 | 2020 | 190 | 0.180 |
Why?
|
Anxiety | 6 | 2023 | 4297 | 0.180 |
Why?
|
Vaccines | 2 | 2018 | 822 | 0.180 |
Why?
|
Brain Mapping | 3 | 2014 | 6669 | 0.180 |
Why?
|
Parahippocampal Gyrus | 1 | 2020 | 116 | 0.180 |
Why?
|
Apolipoprotein E4 | 5 | 2021 | 668 | 0.180 |
Why?
|
Dermatologic Agents | 1 | 2023 | 278 | 0.170 |
Why?
|
Middle Aged | 52 | 2023 | 213383 | 0.170 |
Why?
|
Infrared Rays | 2 | 2018 | 249 | 0.170 |
Why?
|
Adrenergic beta-2 Receptor Agonists | 1 | 2020 | 104 | 0.170 |
Why?
|
Protein Precursors | 1 | 2024 | 1154 | 0.170 |
Why?
|
Radiography, Dual-Energy Scanned Projection | 1 | 2022 | 197 | 0.170 |
Why?
|
Delirium | 2 | 2021 | 1609 | 0.170 |
Why?
|
Peptide Fragments | 4 | 2014 | 5097 | 0.170 |
Why?
|
Aniline Compounds | 8 | 2017 | 986 | 0.170 |
Why?
|
Neurofilament Proteins | 1 | 2021 | 318 | 0.170 |
Why?
|
Cardiopulmonary Bypass | 2 | 2021 | 1066 | 0.170 |
Why?
|
Acne Vulgaris | 1 | 2023 | 302 | 0.170 |
Why?
|
Stroke | 4 | 2023 | 9981 | 0.160 |
Why?
|
Adjuvants, Immunologic | 3 | 2018 | 1000 | 0.160 |
Why?
|
Foramen Ovale, Patent | 1 | 2021 | 223 | 0.160 |
Why?
|
Neurodegenerative Diseases | 2 | 2023 | 1061 | 0.160 |
Why?
|
Radius Fractures | 1 | 2024 | 501 | 0.160 |
Why?
|
Clinical Chemistry Tests | 1 | 2018 | 61 | 0.160 |
Why?
|
Kidney Calculi | 1 | 2022 | 465 | 0.150 |
Why?
|
Brain-Derived Neurotrophic Factor | 1 | 2021 | 604 | 0.150 |
Why?
|
Vision, Ocular | 1 | 2021 | 464 | 0.150 |
Why?
|
Electroencephalography | 6 | 2023 | 6150 | 0.150 |
Why?
|
Autistic Disorder | 6 | 1992 | 1185 | 0.150 |
Why?
|
Alopecia Areata | 1 | 2019 | 107 | 0.150 |
Why?
|
Ischemic Attack, Transient | 1 | 2023 | 935 | 0.150 |
Why?
|
Brain Ischemia | 2 | 2021 | 3265 | 0.150 |
Why?
|
Ribonucleoproteins | 1 | 2019 | 381 | 0.140 |
Why?
|
Pregnancy Trimester, Third | 1 | 2019 | 571 | 0.140 |
Why?
|
Thiazoles | 8 | 2017 | 1483 | 0.140 |
Why?
|
Receptors, Adrenergic, beta-2 | 1 | 2017 | 202 | 0.140 |
Why?
|
Hippocampus | 4 | 2020 | 3675 | 0.140 |
Why?
|
Hot Flashes | 1 | 2019 | 317 | 0.140 |
Why?
|
C-Reactive Protein | 1 | 2008 | 3778 | 0.140 |
Why?
|
Epilepsy | 2 | 2023 | 3310 | 0.140 |
Why?
|
Magnetic Resonance Imaging | 11 | 2020 | 35421 | 0.140 |
Why?
|
Gaucher Disease | 1 | 2016 | 112 | 0.140 |
Why?
|
Dyskinesia, Drug-Induced | 3 | 1991 | 163 | 0.140 |
Why?
|
Nerve Degeneration | 3 | 2011 | 748 | 0.140 |
Why?
|
Celiac Disease | 1 | 2024 | 785 | 0.130 |
Why?
|
Tropanes | 1 | 2015 | 51 | 0.130 |
Why?
|
Child Health Services | 1 | 2021 | 667 | 0.130 |
Why?
|
Psychomotor Performance | 3 | 2019 | 1901 | 0.130 |
Why?
|
Telephone | 1 | 2019 | 617 | 0.130 |
Why?
|
Diabetes, Gestational | 2 | 2022 | 1184 | 0.130 |
Why?
|
Cardiac Surgical Procedures | 2 | 2020 | 3537 | 0.130 |
Why?
|
Prospective Studies | 14 | 2021 | 53288 | 0.130 |
Why?
|
Pregnancy Trimester, First | 1 | 2019 | 853 | 0.130 |
Why?
|
Hydrocephalus | 1 | 2021 | 748 | 0.130 |
Why?
|
Motor Activity | 2 | 2015 | 2714 | 0.130 |
Why?
|
Respiratory Mechanics | 1 | 2019 | 686 | 0.130 |
Why?
|
Ketamine | 1 | 2020 | 500 | 0.120 |
Why?
|
Lymphedema | 1 | 2021 | 534 | 0.120 |
Why?
|
Radionuclide Imaging | 2 | 2015 | 2031 | 0.120 |
Why?
|
Low Back Pain | 1 | 2023 | 956 | 0.120 |
Why?
|
Parietal Lobe | 2 | 2017 | 838 | 0.120 |
Why?
|
Quantitative Trait Loci | 2 | 2020 | 2019 | 0.120 |
Why?
|
Glucose Tolerance Test | 3 | 2022 | 1150 | 0.120 |
Why?
|
Hallucinations | 2 | 2013 | 360 | 0.120 |
Why?
|
Affect | 1 | 2021 | 1476 | 0.120 |
Why?
|
Awareness | 1 | 2018 | 640 | 0.120 |
Why?
|
Multifactorial Inheritance | 1 | 2021 | 1194 | 0.120 |
Why?
|
Amyloid | 2 | 2023 | 795 | 0.120 |
Why?
|
Schools, Medical | 1 | 2020 | 880 | 0.110 |
Why?
|
Blood Transfusion | 1 | 2020 | 1301 | 0.110 |
Why?
|
Analgesics | 1 | 2020 | 1040 | 0.110 |
Why?
|
Vision Disorders | 1 | 2020 | 1058 | 0.110 |
Why?
|
Environment Design | 1 | 2015 | 178 | 0.110 |
Why?
|
Rectal Neoplasms | 1 | 2022 | 1206 | 0.110 |
Why?
|
Severity of Illness Index | 9 | 2020 | 15540 | 0.110 |
Why?
|
Gene Expression Regulation | 4 | 2018 | 12072 | 0.110 |
Why?
|
Neocortex | 1 | 2016 | 400 | 0.110 |
Why?
|
Follow-Up Studies | 10 | 2021 | 39050 | 0.110 |
Why?
|
Disability Evaluation | 2 | 2018 | 1827 | 0.110 |
Why?
|
Patient Preference | 1 | 2020 | 890 | 0.110 |
Why?
|
Microarray Analysis | 1 | 2015 | 767 | 0.100 |
Why?
|
Staphylococcal Infections | 1 | 2021 | 1400 | 0.100 |
Why?
|
Mental Status Schedule | 2 | 2014 | 321 | 0.100 |
Why?
|
Anemia, Sickle Cell | 1 | 2020 | 1018 | 0.100 |
Why?
|
Faculty, Medical | 1 | 2020 | 1181 | 0.100 |
Why?
|
Atrophy | 2 | 2023 | 1583 | 0.100 |
Why?
|
Synapses | 1 | 2021 | 1728 | 0.100 |
Why?
|
Laser Therapy | 1 | 2018 | 1072 | 0.100 |
Why?
|
Seizures | 2 | 2023 | 2859 | 0.100 |
Why?
|
Genetic Loci | 1 | 2021 | 2575 | 0.100 |
Why?
|
Neural Pathways | 2 | 2021 | 2972 | 0.100 |
Why?
|
Lung Diseases, Interstitial | 1 | 2019 | 808 | 0.100 |
Why?
|
Autoantibodies | 1 | 2019 | 2035 | 0.100 |
Why?
|
Temporal Lobe | 3 | 2017 | 1670 | 0.100 |
Why?
|
Mast Cells | 1 | 2018 | 1544 | 0.100 |
Why?
|
Insulin Resistance | 2 | 2022 | 3864 | 0.100 |
Why?
|
Amyloidogenic Proteins | 2 | 2023 | 152 | 0.090 |
Why?
|
Pain Measurement | 1 | 2020 | 3420 | 0.090 |
Why?
|
Hematopoiesis | 1 | 2020 | 2072 | 0.090 |
Why?
|
Radiopharmaceuticals | 3 | 2017 | 2645 | 0.090 |
Why?
|
Homocysteine | 2 | 2021 | 647 | 0.090 |
Why?
|
Blood Glucose | 2 | 2022 | 6256 | 0.090 |
Why?
|
Students, Medical | 1 | 2023 | 1862 | 0.090 |
Why?
|
Haloperidol | 2 | 1991 | 397 | 0.090 |
Why?
|
Bone Marrow | 1 | 2020 | 2948 | 0.090 |
Why?
|
Influenza Vaccines | 1 | 2017 | 738 | 0.090 |
Why?
|
Neovascularization, Pathologic | 1 | 2020 | 2635 | 0.090 |
Why?
|
Immunoassay | 1 | 2013 | 752 | 0.090 |
Why?
|
Health Promotion | 2 | 2021 | 2205 | 0.090 |
Why?
|
Multiple System Atrophy | 1 | 2011 | 121 | 0.090 |
Why?
|
Personality Assessment | 1 | 1991 | 647 | 0.080 |
Why?
|
Adult | 22 | 2024 | 214055 | 0.080 |
Why?
|
Apolipoproteins E | 4 | 2003 | 1438 | 0.080 |
Why?
|
Interleukin-6 | 1 | 2019 | 3200 | 0.080 |
Why?
|
Amyloid beta-Protein Precursor | 3 | 2013 | 1121 | 0.080 |
Why?
|
Fluorodeoxyglucose F18 | 2 | 2017 | 2016 | 0.080 |
Why?
|
Psychotic Disorders | 1 | 2023 | 3046 | 0.080 |
Why?
|
Health Behavior | 2 | 2018 | 2636 | 0.080 |
Why?
|
Vaccination | 2 | 2018 | 3278 | 0.080 |
Why?
|
Disabled Persons | 1 | 2018 | 1212 | 0.080 |
Why?
|
Insulin | 2 | 2022 | 6580 | 0.080 |
Why?
|
Injections, Intradermal | 2 | 2018 | 117 | 0.080 |
Why?
|
Retrospective Studies | 12 | 2023 | 77449 | 0.080 |
Why?
|
Respiration, Artificial | 1 | 2019 | 2569 | 0.080 |
Why?
|
Patient Compliance | 1 | 2018 | 2684 | 0.080 |
Why?
|
Genome-Wide Association Study | 2 | 2021 | 12261 | 0.080 |
Why?
|
Memantine | 1 | 2008 | 100 | 0.080 |
Why?
|
Simvastatin | 1 | 2010 | 360 | 0.080 |
Why?
|
Age of Onset | 4 | 2015 | 3271 | 0.080 |
Why?
|
Sleep | 1 | 2023 | 4623 | 0.070 |
Why?
|
Dopamine Agents | 1 | 2008 | 189 | 0.070 |
Why?
|
Pneumonia | 1 | 2019 | 2133 | 0.070 |
Why?
|
Alleles | 3 | 2016 | 6933 | 0.070 |
Why?
|
Body Weight | 1 | 2018 | 4669 | 0.070 |
Why?
|
Body Mass Index | 3 | 2021 | 12720 | 0.070 |
Why?
|
Sex Factors | 5 | 2020 | 10397 | 0.070 |
Why?
|
Child | 14 | 2024 | 77709 | 0.070 |
Why?
|
Cholinesterase Inhibitors | 1 | 2008 | 238 | 0.070 |
Why?
|
RNA, Messenger | 3 | 2015 | 13033 | 0.070 |
Why?
|
Heat-Shock Proteins | 1 | 2010 | 822 | 0.070 |
Why?
|
Organ Size | 1 | 2011 | 2252 | 0.070 |
Why?
|
Vascular Diseases | 1 | 2015 | 1161 | 0.070 |
Why?
|
Plaque, Amyloid | 1 | 2010 | 729 | 0.070 |
Why?
|
Histones | 2 | 2017 | 2599 | 0.070 |
Why?
|
Early Diagnosis | 1 | 2010 | 1184 | 0.070 |
Why?
|
Fatty Acid-Binding Proteins | 1 | 2007 | 300 | 0.070 |
Why?
|
Proportional Hazards Models | 5 | 2021 | 12354 | 0.060 |
Why?
|
Morbidity | 2 | 2021 | 1769 | 0.060 |
Why?
|
Pregnancy Complications | 1 | 2019 | 2861 | 0.060 |
Why?
|
Cohort Studies | 8 | 2021 | 40561 | 0.060 |
Why?
|
Lipids | 1 | 2016 | 3305 | 0.060 |
Why?
|
Huntington Disease | 1 | 2011 | 1124 | 0.060 |
Why?
|
Patient Readmission | 1 | 2018 | 3114 | 0.060 |
Why?
|
Age Factors | 6 | 2019 | 18370 | 0.060 |
Why?
|
Life Style | 1 | 2015 | 3835 | 0.060 |
Why?
|
Thiosulfates | 1 | 2023 | 52 | 0.060 |
Why?
|
Speech Discrimination Tests | 1 | 2003 | 35 | 0.060 |
Why?
|
Neurologic Examination | 2 | 2020 | 930 | 0.060 |
Why?
|
Memory Disorders | 5 | 2011 | 1184 | 0.060 |
Why?
|
Genetic Variation | 1 | 2018 | 6544 | 0.060 |
Why?
|
Mental Recall | 2 | 2023 | 1205 | 0.060 |
Why?
|
Internship and Residency | 1 | 2023 | 5788 | 0.050 |
Why?
|
Reproducibility of Results | 7 | 2018 | 19905 | 0.050 |
Why?
|
Prognosis | 6 | 2022 | 29063 | 0.050 |
Why?
|
Bipolar Disorder | 1 | 2020 | 5027 | 0.050 |
Why?
|
Isotretinoin | 1 | 2023 | 114 | 0.050 |
Why?
|
Quality of Life | 2 | 2021 | 12804 | 0.050 |
Why?
|
Registries | 1 | 2018 | 8089 | 0.050 |
Why?
|
Colorectal Neoplasms | 1 | 2022 | 6773 | 0.050 |
Why?
|
Amnesia | 1 | 2004 | 248 | 0.050 |
Why?
|
Genetic Testing | 1 | 2015 | 3444 | 0.050 |
Why?
|
Executive Function | 1 | 2011 | 1364 | 0.050 |
Why?
|
Friends | 1 | 2023 | 154 | 0.050 |
Why?
|
Shoulder | 1 | 2024 | 299 | 0.050 |
Why?
|
Problem Solving | 1 | 2004 | 440 | 0.050 |
Why?
|
Proxy | 1 | 2022 | 144 | 0.050 |
Why?
|
Atrial Fibrillation | 1 | 2020 | 5034 | 0.050 |
Why?
|
Minocycline | 1 | 2023 | 163 | 0.050 |
Why?
|
Florida | 1 | 2023 | 435 | 0.050 |
Why?
|
Pilot Projects | 4 | 2019 | 8324 | 0.050 |
Why?
|
Predictive Value of Tests | 6 | 2018 | 15076 | 0.050 |
Why?
|
Weaning | 1 | 2021 | 105 | 0.050 |
Why?
|
Verbal Learning | 3 | 2014 | 467 | 0.050 |
Why?
|
Follicular Phase | 1 | 2021 | 153 | 0.050 |
Why?
|
Enhancer Elements, Genetic | 2 | 2018 | 1341 | 0.050 |
Why?
|
Tomography Scanners, X-Ray Computed | 1 | 2022 | 168 | 0.050 |
Why?
|
Time Factors | 7 | 2023 | 40075 | 0.050 |
Why?
|
Discrimination Learning | 1 | 2003 | 280 | 0.050 |
Why?
|
Cholesterol | 1 | 2010 | 2917 | 0.050 |
Why?
|
Receptors, GABA | 1 | 2023 | 288 | 0.050 |
Why?
|
Semantics | 1 | 2004 | 584 | 0.050 |
Why?
|
Bone Plates | 1 | 2024 | 468 | 0.050 |
Why?
|
Analysis of Variance | 2 | 1997 | 6365 | 0.050 |
Why?
|
Gene Expression | 4 | 2011 | 7799 | 0.050 |
Why?
|
Cyclothymic Disorder | 1 | 2020 | 41 | 0.050 |
Why?
|
Survival Analysis | 3 | 2021 | 10252 | 0.050 |
Why?
|
Infarction | 1 | 2021 | 244 | 0.050 |
Why?
|
Receptors, Glutamate | 1 | 2001 | 232 | 0.050 |
Why?
|
Spin Labels | 1 | 2021 | 332 | 0.050 |
Why?
|
Ventriculoperitoneal Shunt | 1 | 2021 | 194 | 0.050 |
Why?
|
Pregnancy | 4 | 2023 | 29144 | 0.040 |
Why?
|
Mice | 10 | 2023 | 81183 | 0.040 |
Why?
|
Artifacts | 1 | 2008 | 1904 | 0.040 |
Why?
|
Mutation | 3 | 2021 | 29786 | 0.040 |
Why?
|
Technology | 1 | 2022 | 305 | 0.040 |
Why?
|
Case-Control Studies | 6 | 2020 | 21746 | 0.040 |
Why?
|
Cellulitis | 1 | 2021 | 206 | 0.040 |
Why?
|
Infarction, Middle Cerebral Artery | 1 | 2023 | 475 | 0.040 |
Why?
|
Double-Blind Method | 5 | 2023 | 12026 | 0.040 |
Why?
|
Pick Disease of the Brain | 1 | 2000 | 43 | 0.040 |
Why?
|
Regression Analysis | 3 | 2009 | 6459 | 0.040 |
Why?
|
Adolescent | 8 | 2019 | 85781 | 0.040 |
Why?
|
Image Interpretation, Computer-Assisted | 2 | 2011 | 3327 | 0.040 |
Why?
|
Aspartic Acid Endopeptidases | 1 | 2001 | 311 | 0.040 |
Why?
|
Heart Failure | 1 | 2023 | 10900 | 0.040 |
Why?
|
Linear Models | 3 | 2014 | 5952 | 0.040 |
Why?
|
Levodopa | 2 | 2012 | 219 | 0.040 |
Why?
|
Mental Disorders | 1 | 2018 | 6600 | 0.040 |
Why?
|
Hand | 1 | 2024 | 884 | 0.040 |
Why?
|
Exercise | 1 | 2015 | 5615 | 0.040 |
Why?
|
Animals | 12 | 2023 | 168757 | 0.040 |
Why?
|
Mice, Inbred C57BL | 6 | 2019 | 21827 | 0.040 |
Why?
|
Adrenergic beta-1 Receptor Agonists | 1 | 2017 | 15 | 0.040 |
Why?
|
Tumor Necrosis Factor-alpha | 2 | 2020 | 4420 | 0.040 |
Why?
|
Career Mobility | 1 | 2020 | 262 | 0.040 |
Why?
|
Social Isolation | 1 | 2021 | 365 | 0.040 |
Why?
|
Poverty | 2 | 2021 | 2660 | 0.040 |
Why?
|
Agnosia | 1 | 2018 | 66 | 0.040 |
Why?
|
Abscess | 1 | 2021 | 607 | 0.040 |
Why?
|
Multicenter Studies as Topic | 1 | 2023 | 1677 | 0.040 |
Why?
|
DNA, Mitochondrial | 1 | 2023 | 817 | 0.040 |
Why?
|
Cartilage | 1 | 2021 | 818 | 0.040 |
Why?
|
Fracture Fixation, Internal | 1 | 2024 | 917 | 0.040 |
Why?
|
Mannose-Binding Lectins | 1 | 2017 | 100 | 0.040 |
Why?
|
Range of Motion, Articular | 1 | 2024 | 1578 | 0.040 |
Why?
|
Perfusion | 1 | 2021 | 1360 | 0.040 |
Why?
|
Introns | 1 | 1999 | 991 | 0.040 |
Why?
|
Albuterol | 1 | 2017 | 208 | 0.040 |
Why?
|
Treatment Outcome | 5 | 2024 | 63114 | 0.040 |
Why?
|
Memory, Short-Term | 1 | 2003 | 975 | 0.040 |
Why?
|
Receptors, CCR2 | 1 | 2017 | 212 | 0.040 |
Why?
|
Uric Acid | 1 | 2022 | 766 | 0.030 |
Why?
|
Glasgow Coma Scale | 1 | 2018 | 570 | 0.030 |
Why?
|
Norway | 1 | 2017 | 448 | 0.030 |
Why?
|
Child Behavior Disorders | 2 | 1992 | 807 | 0.030 |
Why?
|
Haplotypes | 1 | 2023 | 2779 | 0.030 |
Why?
|
Ethylene Glycols | 1 | 2017 | 156 | 0.030 |
Why?
|
Maximum Tolerated Dose | 1 | 2018 | 892 | 0.030 |
Why?
|
Hyperinsulinism | 1 | 2019 | 415 | 0.030 |
Why?
|
ROC Curve | 2 | 2014 | 3527 | 0.030 |
Why?
|
Association Learning | 1 | 1997 | 224 | 0.030 |
Why?
|
Massachusetts | 3 | 2015 | 8663 | 0.030 |
Why?
|
Drainage | 1 | 2021 | 1142 | 0.030 |
Why?
|
Propranolol | 1 | 2017 | 502 | 0.030 |
Why?
|
Cells, Cultured | 3 | 2018 | 19229 | 0.030 |
Why?
|
Cell Movement | 2 | 2018 | 5217 | 0.030 |
Why?
|
Tomography, Emission-Computed, Single-Photon | 1 | 2021 | 1107 | 0.030 |
Why?
|
Substantia Nigra | 1 | 2017 | 353 | 0.030 |
Why?
|
Spatial Behavior | 1 | 1995 | 90 | 0.030 |
Why?
|
Psychiatry | 1 | 1988 | 1695 | 0.030 |
Why?
|
Imaging, Three-Dimensional | 1 | 2008 | 4042 | 0.030 |
Why?
|
Independent Living | 1 | 2019 | 568 | 0.030 |
Why?
|
Injury Severity Score | 1 | 2018 | 1014 | 0.030 |
Why?
|
Forkhead Transcription Factors | 1 | 2022 | 1613 | 0.030 |
Why?
|
Educational Status | 1 | 2003 | 2540 | 0.030 |
Why?
|
Risk Factors | 7 | 2021 | 72290 | 0.030 |
Why?
|
Acetylation | 1 | 2017 | 1085 | 0.030 |
Why?
|
Respiratory Function Tests | 1 | 2019 | 1616 | 0.030 |
Why?
|
Neurons | 3 | 2010 | 9338 | 0.030 |
Why?
|
Anti-Bacterial Agents | 2 | 2024 | 7181 | 0.030 |
Why?
|
India | 1 | 2020 | 2197 | 0.030 |
Why?
|
Image Processing, Computer-Assisted | 1 | 2011 | 8949 | 0.030 |
Why?
|
Neoplasm Invasiveness | 1 | 2022 | 3616 | 0.030 |
Why?
|
Space Perception | 1 | 1997 | 475 | 0.030 |
Why?
|
Immunization | 1 | 2018 | 1256 | 0.030 |
Why?
|
Cytokines | 2 | 2019 | 7322 | 0.030 |
Why?
|
Lectins, C-Type | 1 | 2017 | 588 | 0.030 |
Why?
|
Phantoms, Imaging | 1 | 2022 | 2480 | 0.030 |
Why?
|
Breast Neoplasms | 1 | 2021 | 20822 | 0.030 |
Why?
|
Mass Spectrometry | 1 | 2021 | 2203 | 0.030 |
Why?
|
Mice, Hairless | 1 | 1993 | 41 | 0.030 |
Why?
|
Adaptive Immunity | 1 | 2018 | 713 | 0.030 |
Why?
|
Diagnosis, Differential | 4 | 2015 | 12959 | 0.030 |
Why?
|
Kaplan-Meier Estimate | 2 | 2015 | 6538 | 0.030 |
Why?
|
Algorithms | 2 | 2017 | 13881 | 0.030 |
Why?
|
Risk | 2 | 2017 | 9687 | 0.030 |
Why?
|
Genotype | 4 | 2016 | 12951 | 0.030 |
Why?
|
Cerebral Hemorrhage | 1 | 2005 | 2647 | 0.030 |
Why?
|
Physical Examination | 1 | 2019 | 1237 | 0.030 |
Why?
|
Young Adult | 4 | 2020 | 56430 | 0.030 |
Why?
|
Antigens, Surface | 1 | 2017 | 1663 | 0.030 |
Why?
|
Minority Groups | 1 | 2020 | 1223 | 0.030 |
Why?
|
Family Health | 1 | 2018 | 1282 | 0.030 |
Why?
|
Administration, Oral | 1 | 2020 | 3913 | 0.030 |
Why?
|
Sensitivity and Specificity | 3 | 2014 | 14722 | 0.030 |
Why?
|
Geographic Information Systems | 1 | 2015 | 281 | 0.030 |
Why?
|
Hair Diseases | 1 | 1993 | 74 | 0.030 |
Why?
|
Cerebrovascular Circulation | 1 | 2023 | 2731 | 0.030 |
Why?
|
Pimozide | 1 | 1992 | 21 | 0.030 |
Why?
|
Apolipoprotein E3 | 1 | 2012 | 97 | 0.030 |
Why?
|
Depressive Disorder, Major | 1 | 2010 | 4644 | 0.030 |
Why?
|
Diagnostic Self Evaluation | 1 | 2014 | 230 | 0.030 |
Why?
|
Patient Admission | 1 | 2019 | 1380 | 0.030 |
Why?
|
Warfarin | 1 | 2020 | 1496 | 0.030 |
Why?
|
Visual Acuity | 1 | 2020 | 2530 | 0.030 |
Why?
|
Adrenergic beta-Antagonists | 1 | 2017 | 1240 | 0.030 |
Why?
|
Incidence | 2 | 2021 | 20947 | 0.020 |
Why?
|
Psychometrics | 1 | 2021 | 3002 | 0.020 |
Why?
|
Carbon Radioisotopes | 1 | 2012 | 577 | 0.020 |
Why?
|
Antiparkinson Agents | 1 | 2012 | 184 | 0.020 |
Why?
|
Actigraphy | 1 | 2015 | 488 | 0.020 |
Why?
|
Child, Preschool | 8 | 2024 | 41006 | 0.020 |
Why?
|
Leptin | 1 | 2019 | 1599 | 0.020 |
Why?
|
Carbamazepine | 1 | 1992 | 229 | 0.020 |
Why?
|
Reactive Oxygen Species | 1 | 2018 | 2077 | 0.020 |
Why?
|
Mice, Inbred CBA | 1 | 2011 | 448 | 0.020 |
Why?
|
Hydroxycholesterols | 1 | 2010 | 25 | 0.020 |
Why?
|
Neuroprotective Agents | 1 | 2017 | 941 | 0.020 |
Why?
|
Genetic Association Studies | 1 | 2020 | 2703 | 0.020 |
Why?
|
Transcription Factors | 1 | 2010 | 12208 | 0.020 |
Why?
|
Bacteria | 1 | 2021 | 2114 | 0.020 |
Why?
|
Disease Models, Animal | 3 | 2023 | 18029 | 0.020 |
Why?
|
Prevalence | 3 | 2013 | 15226 | 0.020 |
Why?
|
Ligands | 1 | 2017 | 3282 | 0.020 |
Why?
|
Delusions | 1 | 2012 | 300 | 0.020 |
Why?
|
Cocaine | 1 | 2015 | 1007 | 0.020 |
Why?
|
Reference Values | 2 | 2010 | 4982 | 0.020 |
Why?
|
Tumor Microenvironment | 1 | 2022 | 3586 | 0.020 |
Why?
|
Patient Discharge | 1 | 2023 | 3313 | 0.020 |
Why?
|
HIV Infections | 1 | 2016 | 16718 | 0.020 |
Why?
|
Weight Loss | 1 | 2021 | 2622 | 0.020 |
Why?
|
Diffusion Magnetic Resonance Imaging | 1 | 2021 | 2737 | 0.020 |
Why?
|
Mitochondria | 1 | 2023 | 3520 | 0.020 |
Why?
|
Stereotyped Behavior | 1 | 1990 | 136 | 0.020 |
Why?
|
Promoter Regions, Genetic | 2 | 2017 | 5867 | 0.020 |
Why?
|
Disease Susceptibility | 1 | 2016 | 1782 | 0.020 |
Why?
|
Benzothiazoles | 1 | 2010 | 248 | 0.020 |
Why?
|
Logistic Models | 2 | 2014 | 13408 | 0.020 |
Why?
|
Polymorphism, Genetic | 1 | 1999 | 4328 | 0.020 |
Why?
|
Enzyme-Linked Immunosorbent Assay | 2 | 2008 | 3870 | 0.020 |
Why?
|
Decision Making | 1 | 2022 | 3887 | 0.020 |
Why?
|
Immunohistochemistry | 1 | 2022 | 11366 | 0.020 |
Why?
|
Infant | 4 | 2024 | 35136 | 0.020 |
Why?
|
Mice, Transgenic | 3 | 2011 | 9734 | 0.020 |
Why?
|
Protein Multimerization | 1 | 2013 | 970 | 0.020 |
Why?
|
Perception | 1 | 2015 | 1198 | 0.020 |
Why?
|
Length of Stay | 1 | 2021 | 6309 | 0.020 |
Why?
|
Antiretroviral Therapy, Highly Active | 1 | 2016 | 1873 | 0.020 |
Why?
|
Lithium | 1 | 1991 | 601 | 0.020 |
Why?
|
Naltrexone | 1 | 1990 | 307 | 0.020 |
Why?
|
Zebrafish | 1 | 2018 | 2994 | 0.020 |
Why?
|
Hospitals | 1 | 2021 | 3952 | 0.020 |
Why?
|
Visual Perception | 1 | 1995 | 1420 | 0.020 |
Why?
|
Imipramine | 1 | 1986 | 97 | 0.020 |
Why?
|
Aggression | 1 | 1992 | 753 | 0.020 |
Why?
|
United States | 3 | 2020 | 69872 | 0.020 |
Why?
|
In Situ Hybridization | 2 | 2001 | 1950 | 0.020 |
Why?
|
Immunity, Innate | 1 | 2018 | 2958 | 0.020 |
Why?
|
Time | 1 | 2008 | 542 | 0.020 |
Why?
|
Schools | 1 | 2015 | 1433 | 0.020 |
Why?
|
Histone Deacetylase Inhibitors | 1 | 2011 | 789 | 0.020 |
Why?
|
Intensive Care Units | 1 | 2019 | 3679 | 0.020 |
Why?
|
Dendrites | 1 | 2008 | 485 | 0.020 |
Why?
|
Multivariate Analysis | 1 | 2019 | 12245 | 0.020 |
Why?
|
Selection Bias | 1 | 2007 | 371 | 0.020 |
Why?
|
Cerebral Amyloid Angiopathy | 2 | 2005 | 859 | 0.020 |
Why?
|
Factor Analysis, Statistical | 1 | 1988 | 977 | 0.020 |
Why?
|
Anticoagulants | 1 | 2020 | 4599 | 0.020 |
Why?
|
Frontal Lobe | 1 | 2011 | 1406 | 0.020 |
Why?
|
HSP70 Heat-Shock Proteins | 1 | 2007 | 404 | 0.020 |
Why?
|
Cell Count | 1 | 2008 | 1856 | 0.020 |
Why?
|
Medicaid | 1 | 2018 | 2736 | 0.020 |
Why?
|
Tissue Distribution | 1 | 2008 | 2327 | 0.020 |
Why?
|
Databases, Genetic | 1 | 2010 | 1783 | 0.010 |
Why?
|
Hypercholesterolemia | 1 | 2010 | 1151 | 0.010 |
Why?
|
Transcription, Genetic | 1 | 2017 | 7722 | 0.010 |
Why?
|
Dopamine | 1 | 2010 | 1591 | 0.010 |
Why?
|
Diagnostic and Statistical Manual of Mental Disorders | 1 | 2010 | 1953 | 0.010 |
Why?
|
Pandemics | 1 | 2023 | 8388 | 0.010 |
Why?
|
Clinical Trials as Topic | 1 | 2019 | 7913 | 0.010 |
Why?
|
Anticholesteremic Agents | 1 | 2010 | 979 | 0.010 |
Why?
|
Vitamin B 12 | 1 | 2005 | 527 | 0.010 |
Why?
|
Emergency Service, Hospital | 1 | 2021 | 7659 | 0.010 |
Why?
|
Phosphorylation | 1 | 2013 | 8436 | 0.010 |
Why?
|
Cholinesterases | 1 | 2001 | 34 | 0.010 |
Why?
|
Movement | 1 | 2008 | 1471 | 0.010 |
Why?
|
Primary Health Care | 1 | 2018 | 4558 | 0.010 |
Why?
|
Feasibility Studies | 1 | 2011 | 5078 | 0.010 |
Why?
|
Cell Line, Tumor | 1 | 2017 | 16689 | 0.010 |
Why?
|
Receptors, Purinergic P1 | 1 | 2001 | 109 | 0.010 |
Why?
|
Receptors, Muscarinic | 1 | 2001 | 156 | 0.010 |
Why?
|
Molecular Sequence Data | 2 | 2008 | 18111 | 0.010 |
Why?
|
Receptors, Dopamine | 1 | 2001 | 295 | 0.010 |
Why?
|
Autoradiography | 1 | 2001 | 745 | 0.010 |
Why?
|
Creatinine | 1 | 2005 | 1919 | 0.010 |
Why?
|
Mice, Inbred DBA | 1 | 2001 | 642 | 0.010 |
Why?
|
Delivery of Health Care | 1 | 2018 | 5319 | 0.010 |
Why?
|
Genetic Predisposition to Disease | 1 | 2021 | 17446 | 0.010 |
Why?
|
Oxygen | 1 | 2011 | 4189 | 0.010 |
Why?
|
Apolipoprotein E2 | 1 | 1999 | 127 | 0.010 |
Why?
|
Receptors, Metabotropic Glutamate | 1 | 2001 | 211 | 0.010 |
Why?
|
Combined Modality Therapy | 1 | 1991 | 8642 | 0.010 |
Why?
|
Receptors, AMPA | 1 | 2001 | 331 | 0.010 |
Why?
|
Tomography, X-Ray Computed | 1 | 2022 | 20129 | 0.010 |
Why?
|
Reading | 1 | 2003 | 558 | 0.010 |
Why?
|
Causality | 1 | 2005 | 1275 | 0.010 |
Why?
|
Folic Acid | 1 | 2005 | 1300 | 0.010 |
Why?
|
Patient Selection | 1 | 2011 | 4215 | 0.010 |
Why?
|
Databases, Factual | 1 | 2014 | 7729 | 0.010 |
Why?
|
Computational Biology | 1 | 2010 | 3521 | 0.010 |
Why?
|
Drug Therapy, Combination | 1 | 2008 | 6489 | 0.010 |
Why?
|
Image Enhancement | 1 | 2008 | 2921 | 0.010 |
Why?
|
Antipsychotic Agents | 1 | 1991 | 3057 | 0.010 |
Why?
|
Endopeptidases | 1 | 2001 | 772 | 0.010 |
Why?
|
Amyloid Precursor Protein Secretases | 1 | 2001 | 584 | 0.010 |
Why?
|
Obesity | 1 | 2019 | 12745 | 0.010 |
Why?
|
Amino Acid Sequence | 1 | 2008 | 13815 | 0.010 |
Why?
|
Blood Platelets | 1 | 1986 | 2508 | 0.010 |
Why?
|
Receptors, N-Methyl-D-Aspartate | 1 | 2001 | 895 | 0.010 |
Why?
|
Comorbidity | 1 | 2010 | 10388 | 0.010 |
Why?
|
Nurses | 1 | 2005 | 2461 | 0.010 |
Why?
|
DNA Primers | 1 | 1999 | 2892 | 0.010 |
Why?
|
Likelihood Functions | 1 | 1997 | 1005 | 0.010 |
Why?
|
Genetic Linkage | 1 | 1999 | 2421 | 0.010 |
Why?
|
Cerebellum | 1 | 2001 | 1488 | 0.010 |
Why?
|
Task Performance and Analysis | 1 | 1997 | 780 | 0.010 |
Why?
|
Lymphocyte Culture Test, Mixed | 1 | 1993 | 517 | 0.010 |
Why?
|
Reverse Transcriptase Polymerase Chain Reaction | 1 | 1999 | 4751 | 0.010 |
Why?
|
Rats | 1 | 2008 | 24260 | 0.010 |
Why?
|
Ultrasonography | 1 | 2005 | 5985 | 0.010 |
Why?
|
Pattern Recognition, Visual | 1 | 1997 | 824 | 0.010 |
Why?
|
Reaction Time | 1 | 1997 | 2097 | 0.010 |
Why?
|
Gene Expression Profiling | 1 | 2007 | 9438 | 0.010 |
Why?
|
Cytotoxicity, Immunologic | 1 | 1993 | 1369 | 0.010 |
Why?
|
Immunophenotyping | 1 | 1993 | 1880 | 0.000 |
Why?
|
Schizophrenia | 1 | 1986 | 6882 | 0.000 |
Why?
|
Immune System | 1 | 1993 | 805 | 0.000 |
Why?
|
DNA | 1 | 1999 | 7301 | 0.000 |
Why?
|
Base Sequence | 1 | 1996 | 12797 | 0.000 |
Why?
|
Macromolecular Substances | 1 | 1986 | 1454 | 0.000 |
Why?
|
Flow Cytometry | 1 | 1993 | 5974 | 0.000 |
Why?
|
Serotonin | 1 | 1986 | 1017 | 0.000 |
Why?
|
Lymphocyte Activation | 1 | 1993 | 5524 | 0.000 |
Why?
|
Recurrence | 1 | 1991 | 8340 | 0.000 |
Why?
|
Kinetics | 1 | 1986 | 6473 | 0.000 |
Why?
|
T-Lymphocytes | 1 | 1993 | 10180 | 0.000 |
Why?
|
Chronic Disease | 1 | 1986 | 9146 | 0.000 |
Why?
|